Project dates: May 2019 - December 2021
This proof-of-concept study aimed to evaluate a partner services case findings and treatment strategy to achieve injection network level hepatitis C micro-elimination.
After identification of incident HCV infection the partner services model included:
- Evaluation of the incident infections injection network utilizing proximal partner identification
- Incentivized partner linkage and screening
- Transmission root evaluation utilizing next-generation HCV sequencing, and
- Injection network overlap treatment.